Medipal HoldingsMEDIPAL HOLDINGS CORPORATION7459東証プライム卸売業FY ending Mar 2026, consolidated, J-GAAP
About 66% of Medipal Holdings's sales come from Prescription Pharmaceutical Wholesale Business, with Cosmetics, Daily Necessities and OTC Pharmaceutical Wholesale Business and Animal Health Products and Food Processing Raw Materials Wholesale Business making up much of the rest.
Out of every ¥100 of sales, about ¥1 is left as operating profit.
For every ¥100 Medipal Holdings sells, how much goes where, and how much is kept.
Margin funnel (derived from reported values)Gross margin 7.3% → Operating margin 1.6% → Net margin 1.2%
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.